Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastrointest Oncol. Jul 15, 2013; 5(7): 159-170
Published online Jul 15, 2013. doi: 10.4251/wjgo.v5.i7.159
Table 1 Observed survival of a series of 29 patients with resected hilar cholangiocarcinoma
Period (yr)Observed survival (95%CI)
168.4 (51.3-85.5)
239.6 (21.5-57.7)
335.6 (17.7-53.5)
431.2 (13.5-48.9)
522.3 (6.2-38.4)